Literature DB >> 17925333

CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis.

Mark J Bolland1, Andrew B Grey, Greg D Gamble, Ian R Reid.   

Abstract

CONTEXT: HIV infection has been associated with low bone mineral density (BMD) in many cross-sectional studies, although longitudinal studies have not demonstrated accelerated bone loss. The cross-sectional studies may have been confounded by the failure to control for low body weight in HIV-infected patients.
OBJECTIVE: Our objective was to determine whether low body weight might explain the association of HIV infection with low BMD. DATA SOURCES: MEDLINE and EMBASE were searched for English language studies published from 1966 to March 2007, and conference abstracts prior to 2007 were hand-searched. STUDY SELECTION: All studies reporting BMD and weight or body mass index in adult patients with HIV and a healthy age- and sex-comparable control group were included. Nine of 40 identified studies and one of 68 identified abstracts were eligible. DATA SYNTHESIS: We adjusted for the between-groups weight differences using regression coefficients from published cohorts of healthy men and women. On average, HIV-infected patients were 5.1 kg [95% confidence interval (CI), -6.8, -3.4; P < 0.001] lighter than controls. At all skeletal sites, unadjusted BMD was lower by 4.4-7.0% in the HIV-infected groups than the controls (P < 0.01). After adjustment for body weight, residual between-groups differences in BMD were small (2.2-4.7%) [lumbar spine, -0.02 (95% CI, -0.05, 0.01) g/cm2; P = 0.12; total hip, -0.02 (95% CI, -0.04, 0.00) g/cm2; P = 0.031; femoral neck, -0.04 (95% CI, -0.07, -0.01) g/cm2; P = 0.013; and total body, -0.03 (95% CI, -0.07, 0.01) g/cm2, P = 0.11].
CONCLUSION: HIV-infected patients are lighter than controls and low body weight may largely account for the high prevalence of low BMD reported in HIV-infected patients. However, in the setting of current treatment practice, HIV infection per se is not a risk factor for low BMD.

Entities:  

Mesh:

Year:  2007        PMID: 17925333     DOI: 10.1210/jc.2007-1660

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  45 in total

1.  Relationships Between Physical Activity and Bone Density in People Living with HIV: Results from the SATURN-HIV Study.

Authors:  Joseph D Perazzo; Allison R Webel; S M Khurshid Alam; Abdus Sattar; Grace A McComsey
Journal:  J Assoc Nurses AIDS Care       Date:  2018-03-28       Impact factor: 1.354

2.  Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey.

Authors:  Charles D Burger; Aimee J Foreman; Dave P Miller; Robert E Safford; Michael D McGoon; David B Badesch
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

3.  Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.

Authors:  Kristine M Erlandson; Douglas Kitch; Camlin Tierney; Paul E Sax; Eric S Daar; Pablo Tebas; Kathleen Melbourne; Belinda Ha; Nasreen C Jahed; Grace A McComsey
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

Review 4.  Incident fractures in HIV-infected individuals: a systematic review and meta-analysis.

Authors:  Stephanie Shiau; Emily C Broun; Stephen M Arpadi; Michael T Yin
Journal:  AIDS       Date:  2013-07-31       Impact factor: 4.177

5.  Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.

Authors:  Denise L Jacobson; Donna Spiegelman; Tamsin K Knox; Ira B Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

Review 6.  Geriatric syndromes: new frontiers in HIV and sarcopenia.

Authors:  Kellie L Hawkins; Todd T Brown; Joseph B Margolick; Kristine M Erlandson
Journal:  AIDS       Date:  2017-06-01       Impact factor: 4.177

7.  Bone mineral density in children and adolescents with perinatal HIV infection.

Authors:  Linda A DiMeglio; JiaJia Wang; George K Siberry; Tracie L Miller; Mitchell E Geffner; Rohan Hazra; William Borkowsky; Janet S Chen; Laurie Dooley; Kunjal Patel; Russell B van Dyke; Roger A Fielding; Yared Gurmu; Denise L Jacobson
Journal:  AIDS       Date:  2013-01-14       Impact factor: 4.177

8.  Women, Aging, and HIV: Clinical Issues and Management Strategies.

Authors:  Julie A Womack; Cynthia A Brandt; Amy C Justice
Journal:  J Nurse Pract       Date:  2014-06-01       Impact factor: 0.767

9.  Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.

Authors:  Michael T Yin; Don J McMahon; David C Ferris; Chiyuan A Zhang; Aimee Shu; Ronald Staron; Ivelisse Colon; Jeffrey Laurence; Jay F Dobkin; Scott M Hammer; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

10.  Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.

Authors:  K M Klassen; M G Kimlin; C K Fairley; S Emery; P H Anderson; P R Ebeling
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.